合并与不合并HIV感染的老年人群中谵妄:酒精与神经活性药物的作用
基于VACS队列2007–2019年数据,比较合并HIV(PWH)与不合并HIV(PWoH)老年人住院谵妄的绝对与相对风险。PWH谵妄发生率高于PWoH(5.6 vs 5.0/1000人年)。多变量分析显示抗胆碱能及非抗胆碱能神经活性药物计数与酒精使用水平均与谵妄呈独立剂量反应关联。
要点
- PWH谵妄发生率为5.6/1000人年,高于PWoH的5.0/1000人年。
- 抗胆碱能与非抗胆碱能神经活性药物计数与谵妄呈独立剂量反应关联。
- 酒精使用水平与谵妄呈独立剂量反应关联,减少饮酒或可降低谵妄风险。
核心结论
- 减少酒精使用并限制神经认知活性药物使用,可能有助于降低谵妄的额外发生率,尤其在PWH中。
研究设计与样本
- 利用VACS队列比较2007–2019年PWH与PWoH住院谵妄的绝对与相对风险。
- 按年龄、种族/民族、性别、HIV状态、基线年份和观察时间,为每例病例匹配最多5名对照。
- 药物暴露取索引日期前45至3天,分为抗胆碱能NCAM、非抗胆碱能NCAM和非NCAM并计数。
- 采用logistic回归按HIV状态分层计算谵妄与药物计数的比值比(OR),并调整人口学、疾病严重度和相关诊断。
主要发现
- PWH谵妄发生率高于PWoH(5.6 [95% CI 5.3-5.9/1000 PY] vs 5.0 [95% CI 4.8-5.1/1000 PY])。
- 多变量分析中,抗胆碱能和非抗胆碱能NCAM计数及酒精使用水平均与谵妄呈强独立剂量反应关联。
关键数值与推荐
- 酒精使用水平采用AUDIT-C定义。
- 药物暴露测量窗口为索引日期前45至3天。
- 药物分类为抗胆碱能NCAM、非抗胆碱能NCAM或非NCAM并生成计数。
临床怎么用
- 对老年患者(尤其PWH)应评估酒精使用并减少神经认知活性药物使用以降低谵妄风险。
- 处方抗胆碱能及非抗胆碱能NCAM时需权衡谵妄风险,定期复核药物清单。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People aging with and without HIV (PWH and PWoH) want to avoid neurocognitive dysfunction, especially delirium. Continued use of alcohol in conjunction with neurocognitively active medications (NCAMs) may be a largely underappreciated cause, especially for PWH who experience polypharmacy a decade earlier than PWoH. We compare absolute and relative risk of delirium among PWH and PWoH by age, level of alcohol use, and exposure to NCAMs. METHODS: Using the VACS cohort, we compare absolute and relative risk of inpatient delirium among PWH and PWoH by age, level of alcohol use, and exposure to NCAMs between 2007 and 2019. We matched each case based on age, race/ethnicity, sex, HIV, baseline year, and observation time with up to 5 controls. The case/control date was defined as date of admission for cases and the date corresponding to the same length of time on study for controls. Level of alcohol use was defined using Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). Medication exposure was measured from 45 to 3 days prior to index date; medications were classified as anticholinergic NCAM, non-anticholinergic NCAM, or non NCAM and counts generated. We used logistic regression to determine odds ratios (ORs) for delirium associated with medication counts stratified by HIV status and adjusted for demographics, severity of illness, and related diagnoses. RESULTS: PWH experienced a higher incidence of delirium (5.6, [95% CI 5.3-5.9/1000 PY]) than PWoH (5.0, [95% CI 4.8-5.1/1000 PY]). In multivariable analysis, anticholinergic and non-anticholinergic NCAM counts and level of alcohol use demonstrated strong independent dose-response associations with delirium. CONCLUSIONS: Decreasing alcohol use and limiting the use of neurocognitively active medications may help decrease excess rates of delirium, especially among PWH.
引用
- Akgün KM, Krishnan S, Tate J, et al. Delirium among people aging with and without HIV: Role of alcohol and Neurocognitively active medications. J Am Geriatr Soc. 2023. PMID: 36786300. doi:10.1111/jgs.18265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。